FDA Considers Approval for Moderna's mRNA Flu Vaccine

Why it matters locally: While not directly impacting Georgia's key industries, the approval of Moderna's mRNA flu vaccine could influence healthcare providers and public health initiatives across the state, including the operations of local hospitals and public health departments.

---

The Food and Drug Administration (FDA) is preparing to issue a ruling on Moderna's messenger RNA (mRNA) flu vaccine. This vaccine, if approved, would become the first mRNA-based influenza shot available commercially. Observers expect the FDA's decision to affect the biotechnology industry broadly.